Affidea

25/02/2026

Affidea is proud to announce that Dr Riaan van Tonder, SVP Clinical Research, Information, and Data Outcomes, will participate in the SCRS Global Summit Europe, taking place on 2–3 March in Amsterdam, the Netherlands.

The Summit is a key forum for advancing dialogue between research sites, sponsors, CROs, and solution providers, all united by a common mission: improving the way are designed, delivered, and experienced by patients, bringing positive clinical outcomes with one goal – saving lives.

We look forward to meaningful conversations on how Affidea’s high-quality research infrastructure, digital capabilities, and patient-centric approach can contribute to more efficient and impactful studies.

Dr Riaan van Tonder shared: “Clinical research is evolving rapidly, and success will belong to those who combine scientific excellence with operational agility and patient focus. Our ambition is to help make more accessible, more efficient, and ultimately more impactful for the communities we serve.”

Meet us at SCRS Global Summit Europe!

24/02/2026

Behind every patient we for, every centre we run, and every milestone we achieve, there are people who show up every day with professionalism, empathy, and a genuine commitment.

We are proud to recognise colleagues who truly represent our in action through their leadership, teamwork, innovation, and dedication to safe, high-quality care.

👏 Congratulations to our 2025 winners:

✨ Affinity Award — Maria Saratzi
✨ Fidelity Award — Alessandro Damosso
✨ Idea Award — Anna Hári-Romvári
✨ Captain Award — Bogdan Scalco
✨ Safety Star Award — Alina Barkauskiene
✨ Extra Mile Award — Noelia Muñoz

Thank you for the example you set every day, for your professionalism, your kindness, and your commitment to patients and colleagues alike. We are proud to have you as part of Affidea. 💙

20/02/2026

No Pain, No Gain? Injury Myths, Rehab Truths & Recovery Explained 🎙️

At Affidea, we believe that clinical excellence goes hand-in-hand with patient empowerment. By sharing specialist knowledge, we ensure our patients have the clarity they need to make the best decisions for their health. That is why we are thrilled to announce the launch of Affidea’s Fortius Clinic . In their first episode, expert consultants Mr. Osama Aweid and Mr. Pieter D'Hooghe sit down with host Talia Lazarus to tackle the biggest misconceptions around knee and ankle injuries.

From professional to everyday patients, they’re breaking down the essential truths about pain, diagnosis, and treatment. This series is our way of providing a "backstage pass" to the world-class expertise that defines the Affidea network.

Congratulations to the Fortius Clinic team on this fantastic initiative!



Listen now on all major platforms: 🔗 https://lnkd.in/dbzZXgzD

Lower Limb Injuries Demystified: Diagnosis, Rehab, and RecoveryIn this episode of Behind the Best, host Talia Lazarus is joined by renowned Fortius consultan...

16/02/2026

Last week, Affidea was honoured to be Lead Partner of the LaingBuisson Out-of-Hospital Healthcare Conference in London, bringing together leaders, policymakers, investors and providers to discuss the future of care beyond the hospital.

The conference opened with a keynote from Guy Blomfield, Affidea’s Group CEO and Chairman of the Management Board, who outlined the structural forces accelerating the shift toward out-of-hospital care across Europe — ageing populations, rising chronic disease and mounting pressure on hospital capacity, as well as patients’ growing expectations for faster access, high-quality and services delivered closer to home. Drawing on Affidea’s pan-European experience, Guy spoke about how integrated community-based care can expand system capacity, reduce waiting times and deliver high-quality care closer to people’s lives.

This was followed by a panel discussion featuring perspectives from delivery, strategy and investment, with contributions from Guy Blomfield (Affidea), Tobias Kösters (L.E.K. Consulting) and Obaid M***i (Morgan Stanley), moderated by Theodore Roberts.

We thank LaingBuisson for convening such an important conversation, our fellow panellists for their insights, and the many professionals who visited the Affidea stand. It was a pleasure to meet so many professionals, including those who experienced our immersive demonstration, stepping virtually inside one of our community-based polyclinics.

Advancing out-of-hospital care requires collaboration across the entire healthcare ecosystem, and we were proud to contribute to this forward-looking dialogue. 💙

10/02/2026

Affidea is proud to be the Lead Partner of the LaingBuisson Out-of-Hospital Healthcare Conference, taking place on 11 February 2026 in London.

The conference will open with a keynote address from Guy Blomfield, Group CEO and Chairman of the Management Board of Affidea, who will share Affidea’s experience in developing and scaling out-of-hospital models across Europe and how these models can support the UK in responding to system pressures, ageing populations and the rising burden of chronic diseases.

Following our CEO’s keynote, Affidea will host a panel discussion exploring how out-of-hospital care can be delivered, financed and scaled sustainably, with contributions from Guy Blomfield, Tobias Kösters from L.E.K. Consulting and Obaid M***i from Morgan Stanley.

The programme will also feature an address from Penny Dash, Chair of the NHS, who will outline the NHS 10-Year Plan for England and the priorities shaping the future of care delivery, alongside a broader agenda of discussions with system leaders, policymakers and industry experts.

We look forward to contributing to an important conversation on how systems can evolve beyond the hospital to deliver care that is more , and centred around people’s lives.

🔗 Explore the agenda and register below: https://www.laingbuissonevents.com/out-of-hospital-healthcare-conference-2026/

06/02/2026

We may speak different languages, but the reasons we chose healthcare are the same. For affinity. For fidelity. And in pursuit of new ideas. Our values can be summed up in a single word — Affidea.

In this video, healthcare professionals from across the Affidea network share what Affinity, Fidelity and Ideas mean to them in their daily work with patients. Through their voices and experiences, these values come to life as trust, collaboration, innovation and genuine human connection.

From clinical excellence to everyday moments of care, Affidea’s values shape how we listen, how we act and how we continuously improve the healthcare experience for the communities we serve across Europe.

This video is a reflection of who we are — a healthcare organisation built around people, driven by quality, and committed to delivering care with empathy, responsibility and purpose. 💙

Affidea. Our values, lived every day.

With: Affidea Lietuva , Affidea Romania , Affidea Switzerland , Fortius Clinic ,

05/02/2026

We are honoured and extremely proud that Affidea Portugal has been awarded the Recommended Brand 2026 seal in the Private Health Groups category by Consumers Trust. 👏

Among 18,639 brands evaluated, only 190 in the country achieved this distinction.

This recognition is powered by our patients’ feedback. It reflects the confidence our patients place in us and the daily commitment of our teams to clinical excellence, quality, and truly human care.

Theodore Kravvas, CEO Affidea Iberia, said: “This recognition is especially meaningful because it comes directly from our patients. Every day, our teams work to deliver healthcare that is reliable, accessible and genuinely centred on people. Seeing this effort recognised by those we care for is a source of pride and a strong motivation to continue raising the standard of care we provide.”

To all Affidea professionals: Thank you. This recognition belongs to you 💙

04/02/2026

Every year, on 4 February, reminds us that cancer touches millions of lives in countless ways, but it never defines who we are. It is a moment to pause and reflect on what truly matters: the people behind every diagnosis, the families around them, and the deeply human stories of fear, strength, resilience, love and hope. 💙

The World Cancer Day campaign “United by Unique” places people at the very centre of . It recognises that cancer is more than a medical condition, it is a profoundly personal journey, shaped by individual needs, experiences and emotions. When care is built with compassion, empathy and understanding, outcomes improve, and trust grows.

At Affidea, this people-centred philosophy guides how we design and deliver across Europe. From early detection and advanced diagnostics to specialised oncology pathways and targeted treatments, our focus is always on providing personalised, precise and integrated care, tailored to each individual.

Across our network, this commitment comes to life every day whether through comprehensive oncology care in Affidea Romania with MedEuropa, specialised breast cancer pathways at Affidea brustCare Brust-Zentrum Zürich, community-based radiotherapy and oncology services delivered by Affidea Polska and Affidea Nu-Med in Poland, or high-quality radiotherapy treatment at Affidea IMC Banja Luka in Bosnia, helping patients move forward with confidence through timely and care.

Across all our centres, we work within multidisciplinary teams, invest in innovation and technology, and continuously refine specialised cancer care pathways, always with one purpose: to deliver that is shaped around each individual and supports them at every step.

Because every experience with cancer is unique and only by standing united we can shape a future where care is defined by empathy and .

30/01/2026

Proud moment for Affidea , our Centre of Excellence in Zurich, Switzerland.🇨🇭

Affidea BrustCare is the first study site in Zurich to enroll a patient in the newly opened NOAX clinical trial.

This milestone reflects our commitment to clinical excellence and to advancing personalised care. 💙

The NOAX trial, initiated by the University Hospital Basel, explores whether patients with clinically node-positive breast cancer undergoing upfront surgery may benefit more from targeted axillary dissection combined with axillary radiotherapy, compared to conventional axillary lymph node dissection — with a strong focus on arm-related quality of life and reducing the risk of lymphedema.

A heartfelt thank you to our dedicated study team, PD Dr. Constanze Elfgen, EMBA Elfgen and Dr. med. Katrin T. for the efficient and fast coordination that made this participation possible.

This is research that truly puts patients first. Well done to everyone involved.👏

https://lnkd.in/eSXyM2RX



With Affidea Switzerland

16/01/2026

Expanding our -based model across Europe

Affidea continues to bring high-quality, specialist healthcare closer to where people live with the official inauguration of a new Affidea community polyclinic in Timișoara, Romania.

Designed as an integrated medical hub, the new clinic brings together multi-specialty consultations, supported by advanced MRI and CT imaging and an on-site laboratory collection point. This structure allows patients to move seamlessly from consultation to diagnosis and onward to treatment within a single, coordinated pathway.

With a network of 75 clinics across 32 cities, Affidea Romania plays a central role in our pan-European out-of-hospital strategy, ensuring that specialised, technology-enabled care is available close to each community we serve.

Razvan Predica, Countries CEO for Romania, Hungary and Greece, and Group Chief Commercial Officer, stated: “Our new clinic in Timișoara is a clear expression of Affidea’s innovative, out-of-hospital, community-based care model. At Affidea, we are rethinking in an innovative way how patients access healthcare, bringing specialist medicine, advanced diagnostics and care pathways together in one seamless journey, close to where people live. This approach allows us to deliver faster, more decisions and better care, built around the needs of each individual patient.”

Dr. Monica Bobitan, Medical Director of Romania, added: “The new Affidea Timișoara clinic was designed fully around this vision: a centre where patients can access, in one integrated setting, all essential specialties together with a modern imaging infrastructure, enabling accurate diagnosis and timely, well-informed treatment decisions.”

Across Europe, the Affidea medical ecosystem continues to evolve as a trusted partner for patients, combining medical expertise, advanced and care pathways that support better . 💙

15/01/2026

What happens when two markets align around one strategy, one culture and one ambition?

Since 2025, Spain and Portugal have been operating together as Affidea Iberia, aligned around a shared strategy, a strong culture of excellence, and the continuous sharing of best practices.

Looking ahead to 2026, Affidea Iberia is focused on further strengthening its out-of-hospital model, expanding its network of community-based , and integrating complementary services such as aesthetic medicine and dentistry, all with one objective - delivering a more , seamless healthcare for patients. 💙

Theodore Kravvas, CEO Affidea Iberia stated: “Together, we are shaping an innovative, efficient and sustainable model which positions Affidea Iberia as a reference in the delivery of personalised healthcare services in Europe. This is not just an operational change. It is a new way of thinking, working and growing together. One Team. One ambition. One vision. One Affidea Iberia.”

▶️ Watch the video to hear directly from Affidea Iberia management about the ambition, priorities and the 2026 journey.

14/01/2026

We are pleased to announce that Affidea has acquired a majority stake in LabPoint from Lindenhofgruppe, strengthening our capabilities in Switzerland.

By bringing together advanced imaging, laboratory testing, pathology and genetics within one integrated network, we continue to build a more precise, personalised and patient-centred care model, close to the communities we serve.

This milestone reinforces our long-term ambition: integrated precision medicine across the entire patient journey.

Dr Charles Niehaus, Executive Director of Affidea Group, stated: “The integration of LabPoint reinforces one of Affidea’s core beliefs: precise diagnosis, built on the convergence of imaging, pathology and genetics are the foundation of modern, medicine. This complementarity opens new opportunities to refine our clinical pathways, and provide physicians with a stronger decision-making foundation, ultimately benefiting the millions of patients we serve across Europe.”

Marc-André Christinat, CEO of Affidea Switzerland, added: “The acquisition of LabPoint is a major milestone for Affidea Switzerland. It enables us to offer a comprehensive, integrated and proximity-based service for the benefit of both patients and healthcare professionals. We are confident that this synergy will allow us to expand our market presence and open the way to new innovations in diagnostics.”

We invite you to read our press release for more information here: https://bit.ly/Affidea_LabPoint